Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Mefford, HC; Zemel, M; Geraghty, E; Cook, J; Clayton, PT; Paul, K; Plecko, B; Mills, PB; Nordli, DR; Gospe, SM.
Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination.
NEUROLOGY. 2015; 85(9): 756-762.
Doi: 10.1212/WNL.0000000000001883
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Paul Karl
-
Plecko Barbara
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
To investigate the role of intragenic deletions of ALDH7A1 in patients with clinical and biochemical evidence of pyridoxine-dependent epilepsy but only a single identifiable mutation in ALDH7A1.
We designed a custom oligonucleotide array with high-density probe coverage across the ALDH7A1 gene. We performed array comparative genomic hybridization in 6 patients with clinical and biochemical evidence of pyridoxine-dependent epilepsy but only a single detectable mutation in ALDH7A1 by sequence analysis.
We found partial deletions of ALDH7A1 in 5 of 6 patients. Breakpoint analysis reveals that the deletions are likely a result of Alu-Alu recombination in all cases. The density of Alu elements within introns of ALDH7A1 suggests susceptibility to recurrent rearrangement.
Patients with clinical pyridoxine-dependent epilepsy and a single identifiable mutation in ALDH7A1 warrant further investigation for copy number changes involving the ALHD7A1 gene.
© 2015 American Academy of Neurology.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aldehyde Dehydrogenase - genetics
-
Comparative Genomic Hybridization -
-
Epilepsy - genetics
-
Humans -
-
Oligonucleotide Array Sequence Analysis - methods
-
Sequence Deletion -